Term
|
Definition
Any chemical that can affect living processes. • Lehne, R.A. (2010). Pharmacology for nursing care (7 th ed.). St. Louis, MI: Saunders Elsevier. A substance that brings about a change in biologic function through its chemical actions. |
|
|
Term
Objective of Drug Therapy |
|
Definition
Provide maximal benefit with minimal harm. |
|
|
Term
Properties of an Ideal Drug |
|
Definition
Effectiveness Safety Selectivity Reversibility Predictability Ease of administration Minimal drug interactions Cost effective |
|
|
Term
Three common ways that drugs are named |
|
Definition
Chemical names (N-acetyl-p-aminophenol, APAP) Generic names (acetaminophen) • Non-proprietary or common name Trade names (Tylenol) • Proprietary or brand name
*** Note that generic names start with a small letter and trade names start with a capital letter. |
|
|
Term
Benefits of using generic drug names in hospital |
|
Definition
• Potentially* less confusion • E.g. Celebrex (celecoxib) & Celexa (citalopram) • Lower cost than brand names More consistent • can be numerous brand names for one drug Help to identify group to which drug belongs • Drugs in same category often share similar properties • “-pril”, “-olol”, “sartan”, |
|
|
Term
Clinical Pharmacology Definition |
|
Definition
Pharmacology (study of drugs and their interactions with living systems) in humans |
|
|
Term
Pharmacotherapeutics Definition |
|
Definition
The use of drugs to: diagnose, prevent, treat a disease |
|
|
Term
Pharmacokinetics vs Pharmacodynamics |
|
Definition
Pharmacokinetics • “What the body does to the drug” • Absorption, distribution, metabolism, excretion •“ADME” Pharmacodynamics • “What the drug does to the body” • How drugs produce their pharmacologic effects • Mechanism of action |
|
|
Term
Three ways that Drugs can cross membranes |
|
Definition
Passage through channels or pores • Usually for small ions or small molecular weight molecules (e.g. potassium) 2. Passage with the aid of a transport system • Transport pumps may or may not require energy (e.g. transport systems in the kidney) 3. Direct penetration of the membrane (Most common) • Passive diffusion through the membrane • Rate of diffusion depends on many factors (Concentration gradient) • Lipid solubility (lipophilicity essential for drugs to cross membranes) • Polar molecules and ions – not lipid soluble and do not cross membranes |
|
|
Term
|
Definition
Movement of a drug from its site of administration into the blood. Certain factors will affect the o Rate & o Amount of drug absorbed |
|
|
Term
Two broad factors that affect absorption |
|
Definition
Drug properties – physical & chemical Site properties – anatomic & physiologic |
|
|
Term
5 Specific factors that affect Drug absorption |
|
Definition
Rate of dissolution E.g. tablets - rapid dissolution could yield more rapid onset Surface area Larger surface area, more drug likely to be absorbed Blood flow More absorption when blood flow is high E.g. insulin (do not massage injection site) Lipid solubility More lipid soluble more readily absorbed Recall the phospholipid bilayer pH partitioning ASA ion trapping example in your book |
|
|
Term
Bioavailability Definition |
|
Definition
Also called F Value
the fraction of unchanged drug reaching the systemic circulation after administration by any route usually indicated as % |
|
|
Term
Bioavailability: Why might F be less than 100%? |
|
Definition
Examples (oral): • Inactivation or destruction in stomach (e.g insulin) • binding/chelating interactions with drugs (iron and dairy) • metabolism in lining of gut, first pass effect (ETOH) • malabsorptive syndromes • pH, gastric emptying, GI mobility • vomiting, etc.
**First pass is an important concept |
|
|
Term
Drug Distribution - Definition and 3 major factors |
|
Definition
Movement of drugs throughout the body
1. Blood flow to tissues o Problem conditions – abscesses, tumours 2. Exiting the vascular space o capillary beds – drugs pass between capillary cells. o BBB - tight junctions in capillary beds o Drugs – pass through - need lipid solubility or transport pump o protein binding - bound and free drug 3. Entering cells o Enter cells for metabolism and excretion & for some, in order to have action |
|
|
Term
Metabolism - Definition, Where most of it occurs |
|
Definition
Enzymatic alteration of drug structure by the microsomal enzyme system (Cytochrome P450) We will abbreviate CYP450 Most drug metabolism occurs in the liver Other organs do take part Lung Lining of the GI kidney |
|
|
Term
Definition of Inducer and Inhibitor in reference to CYP450 |
|
Definition
Drugs metabolized by an enzyme are called SUBSTRATES for that enzyme. o Drugs that inhibit the actions of a particular enzyme are called enzyme INHIBITORs. o Drugs that increase the number of CYP450 enzymes are called an enzyme INDUCER. |
|
|
Term
5 consequences of Metabolism |
|
Definition
Accelerated renal drug excretion 2. Drug inactivation 3. Increased therapeutic action 4. Activation of prodrugs 5. Increased or decreased toxicities Some drugs are highly metabolized by the liver – “high first pass effect” |
|
|
Term
first pass effect: how to avoid it |
|
Definition
Ways to avoid: •Sublingual and IV routes • passages directly into systemic (not portal) circulation e.g. nitroglycerin and morphine have high first pass effects. •Prodrugs • Codeine (methylmorphine) –demethylation to morhine + methyl group Necessary dose conversions: •Explains IV to PO conversions of drugs higher oral dose often necessary due to first pass effect |
|
|
Term
Why do we need to know how much of a drug is renally elimminated? How is the drug dose adjusted to compensate for differences in kidney function? |
|
Definition
Why does this matter? What happens when the kidneys are not functioning normally? Consider the potential consequences of drug accumulation E.g. narrow vs non-narrow therapeutic index/range drugs. E.g. side effects more pronounced – sulfonylureas A drug is primarily eliminated by the kidneys when the renal route accounts for > 50% of the drug’s elimination Clinically Dose adjust based on Creatinine Clearance and guidelines |
|
|
Term
6 Non-renal routes of elimination |
|
Definition
Breast milk Bile Lungs Sweat Saliva Feces |
|
|
Term
Steady State (plateau) - How long does it take to reach? |
|
Definition
Drug given repeatedly at the same dose usually takes 4-5 half lives to get to a steady state concentration. book says 4, some give range of 4-5 we will use 5 for testing and discussion but recall in practice people could use a range!
Regardless of the dosage size, the time required to reach plateau is the same |
|
|
Term
Loading Doses - What is the purpose? |
|
Definition
To achieve a more rapid steady state concentration of the maintenance dose |
|
|
Term
|
Definition
1.Cell membrane embedded enzymes 2.Ligand-gated ion channels 3.G-protein coupled receptor 4.Transcription factors |
|
|
Term
Receptor Selectivity: What do we want in a good target for drug therapy |
|
Definition
Limited number of functions Drug interacting with many versus limited receptors Some single receptors regulate several physiologic effects Can’t always guarantee safety e.g. in Lehne is morphine Since certain receptor classes can produce several effects Morphine pain relief other “unwanted” or side effects can occur respiratory depression constipation |
|
|
Term
Drug-Receptor Interaction: Single vs Modified Occupancy Theory |
|
Definition
Affinity –the strength of attraction between a drug and its receptor High affinity = high potency Intrinsic activity –the ability of a drug to activate a receptor upon binding High intrinsic activity =maximal efficacy |
|
|
Term
Maximal Efficacy Definition |
|
Definition
Largest effect that a drug can produce |
|
|
Term
|
Definition
Refers to the amount of drug we must give to elicit an effect |
|
|
Term
Definition of Receptor Agonist |
|
Definition
Agonist: Medications that mimic the body’s own regulatory molecules to activate receptors Note “activate” ≠ speeding up processes! Agonists can also act to slow processes affinity and high intrinsic activity |
|
|
Term
Definition of Receptor Antagonist + Two categories |
|
Definition
Drugs that prevent the activation of receptors by endogenous regulators and drugs Antagonists - “no effects” on their own on receptor function effects produced are a result of blocking receptors from agonists!! affinity for receptor but no intrinsic activity
Competitive reversible binding compete with agonists for binding sites to overcome antagonism increase agonist concentration
Noncompetitive irreversible binding key ‘welded’ in lock to overcome antagonism new receptors must be made |
|
|
Term
what factors influence the response to competetive antagonists |
|
Definition
The response to an antagonist is determined by the amount of agonist present and their affinity for the receptor If the agonist and antagonist have equal affinity the receptors will be occupied by whichever agent is present in the highest concentration |
|
|
Term
Partial agonist definition |
|
Definition
produce a lower maximal response, even at full receptor occupancy Affinity yet only moderate intrinsic activity |
|
|
Term
Drug responses that do not involve receptors |
|
Definition
Act through physical or chemical interactions Antacids Antiseptics –(ethyl alcohol) Laxative (PEG, mag sulfate) |
|
|
Term
4 major types of drug interactions |
|
Definition
Drug – drug Oral contraceptives and St. John’s Wort (M) Probenecid and penicillin (E) Drug – food Grapefruit juice and simvastatin (Zocor) (M) Drug – disease Beta blockers in patients with asthma Cachexia with highly protein bound drugs* (D) CHF and drugs with mineralocorticoid effects Drug – laboratory Efavirenz (Sustiva) and marijuana testing |
|
|